By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular diagnostic technology firm Quanterix said today that it will work with Germany's Stratec Biomedical in a partnership to develop, manufacture, and market an automated testing tool aimed at the life sciences and medical in vitro diagnostic markets.

The companies will customize Stratec's technology to develop an automated version of Quanterix's Single Molecule Array (SiMoA) technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.